Role of leptin and melanocortin signaling in uremia-associated cachexia - Wikidata - awgldk - TriplyDB

Role of leptin and melanocortin signaling in uremia-associated cachexia

Role of leptin and melanocortin signaling in uremia-associated cachexia

http://www.wikidata.org/entity/Q41966819

about

Insulin resistance in patients with chronic kidney disease Regulation of agouti-related protein messenger ribonucleic acid transcription and peptide secretion by acute and chronic inflammation Inflammation and nutrition in children with chronic kidney disease Mechanisms of metabolic dysfunction in cancer-associated cachexia Oral ghrelin receptor agonist MK-0677 increases serum insulin-like growth factor 1 in hemodialysis patients: a randomized blinded study.Wasting in chronic kidney disease Update on melanocortin interventions for cachexia: progress toward clinical application.Animal models of anorexia and cachexia.Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".Nutritional and anti-inflammatory interventions in chronic heart failure.Genetic and pharmacologic blockade of central melanocortin signaling attenuates cardiac cachexia in rodent models of heart failure Ghrelin in chronic kidney disease.Hypothalamic mechanisms in cachexia.Regulation of lean mass, bone mass, and exercise tolerance by the central melanocortin system Melanocortin antagonism ameliorates muscle wasting and inflammation in chronic kidney disease.Obesity hypertension: the regulatory role of leptin Hormonal regulation of energy-protein homeostasis in hemodialysis patients: an anorexigenic profile that may predispose to adverse cardiovascular outcomes.Pathophysiology and treatment of inflammatory anorexia in chronic disease.Neuropeptides in the pathophysiology and treatment of cachexia.Mechanisms of muscle wasting in chronic kidney disease Physiological roles of the melanocortin MC₃ receptor.Protein-energy wasting and mortality in chronic kidney disease.Longitudinal study of leptin levels in chronic hemodialysis patients.Melanocortin control of energy balance: evidence from rodent models.The role of the central melanocortin system in the regulation of food intake and energy homeostasis: lessons from mouse models.Effect of high saturated free fatty acids feeding on progression of renal failure in rat model of experimental nephrotoxicity.The impact of inflammation on bone mass in children.Cachexia and protein-energy wasting in children with chronic kidney disease.Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic-pituitary-adrenal axis.Leptin in anorexia and cachexia syndrome.Recent advances in obesity: genetics and beyond.Sarcopenia: a major challenge in elderly patients with end-stage renal disease.The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology.Anorexia: a taste of things to come?Dietary protein restriction benefits patients with chronic kidney disease.Impact of uremia on human adipose tissue phenotype.Validating Appetite Assessment Tools Among Patients Receiving Hemodialysis Inflammatory factors and exercise in chronic kidney disease.Gut hormones and the treatment of disease cachexia.Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

P2860

Q21285003-BB567397-D562-4D43-A5D3-073CBDA47654 Q24657720-0B9C17E0-CC32-484B-ACB8-85A84A31A22F Q26751530-135E2F93-E36F-4302-8819-1DCB9A401CDC Q28079213-01744AAE-F9C7-44E7-A4C5-7DC4D100F1C3 Q30252874-CDC042A5-20BD-4795-A9F2-AA15D1495BB2 Q30432774-749F6B0B-267B-41AB-92FF-799AF13427DC Q30433378-10D46F9D-6553-4013-8A59-376929F5456B Q30434298-D279EB08-BE76-4BB8-9C3D-AF15EB64385B Q33611989-9A5375ED-C3C3-472B-93FD-11072864ED4B Q33880185-56A1AC05-F8E4-47DB-8060-11F25904DDCF Q33919515-5CC2417F-2242-4761-9915-A676F0DFD0E6 Q34043086-7DDA8413-A7B5-42A0-871A-ACCD9BB4635E Q34081332-665C287F-DAC4-4CF4-96A5-F2A049C16440 Q34359621-D769D2E7-C2ED-43E4-95A4-789CB68630F1 Q34390204-1C0D2B6F-E504-43AD-849E-C22EA4D6111E Q34496907-9FDE1844-FB0A-41DA-AE56-F37EE0320646 Q34501801-CE1730CC-553C-470E-9BF1-0612ED9ADACE Q34697279-BEA86E51-2492-4963-A88D-A0002975C37F Q34712204-CA5C6793-D936-4D5D-A325-E237D392D97F Q34723810-8CE4E368-EC60-414C-B6DB-D5D32C904760 Q34984895-8BC2810F-4F55-49FF-B4EA-37FD7E920AD4 Q35024794-76C24EBE-5A8E-411F-9695-F2C0116ECA1A Q35094822-3C13D59E-F841-4933-9022-D96661B3E27F Q35103464-A44D4430-7C11-44C9-9C56-1C056ED98BE2 Q35140186-8F720859-0638-40BC-B7E7-AECA93EEBBD3 Q35184313-DE508DB6-897E-4D8A-B767-736C138609E5 Q35226354-4ADB71AB-E955-4AD9-ABDF-DE7177F57446 Q35645564-96CAB8D4-8B93-475B-9A4C-B81B88CE7307 Q35669093-E1003916-5784-4E5A-8A0A-DB38E0750941 Q35829778-9011E08C-AFFA-440B-B4BC-BEE6F32B4A1C Q35855592-C7074DFF-1BCE-4EAC-ACDC-4E3916E51CB7 Q35875692-229D2144-3CA9-4140-95B7-28BB97742E5E Q36003378-0A76BB51-BB42-4C57-9011-BA2ECD0B2596 Q36398304-9D14FFB3-AE50-4E69-AC1B-7C09FA6C7209 Q36410512-0448240E-7E4D-4D26-AACB-4A7FE75FB283 Q36637146-1FF89248-1A1E-4043-9682-93AFAD5CBB4A Q36698195-AC3EFB2E-BA6D-4A98-8C8A-740E939FF851 Q36882794-93088310-A285-4225-8741-BE6A884A0D81 Q37152938-663F95EA-A1FA-4C7D-9E51-6705E1C30711 Q37157903-BFACD9A6-11C1-4FC2-8078-6F8244D22326

P2860

Role of leptin and melanocortin signaling in uremia-associated cachexia

http://www.wikidata.org/entity/Q41966819

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Role of leptin and melanocortin signaling in uremia-associated cachexia

@en

type

label

Role of leptin and melanocortin signaling in uremia-associated cachexia

@en

prefLabel

Role of leptin and melanocortin signaling in uremia-associated cachexia

@en

P1433

Q41966819-F0BE84BB-0A82-4447-8B0D-C165CB671918

P1476

Q41966819-A4875D11-8447-45B2-873A-6A020EE5144E

P2093

Q41966819-07F95EBA-78DE-47CD-8161-53CF92BCC569

Q41966819-4A86E838-1117-448A-8173-432489CF2522

Q41966819-4D51F85B-FD75-4272-8135-61451F9F1D9E

Q41966819-7C83ADE8-9379-4FE8-B45D-C454D3AC10FD

Q41966819-959FD5C6-B08B-41F9-A39C-06C1BE7FAEB3

Q41966819-B72A3BB1-DC78-452F-AB59-FF1FDC663075

P2860

Q41966819-033E124D-A2F6-477F-BB42-0A59BE5854A5

Q41966819-0FF42054-9122-43C3-A1D9-FADE452DDC86

Q41966819-2BC4EEC2-37D3-4114-9746-F6ACD1D549CB

Q41966819-35B9771A-0341-4089-985D-01FDC110235A

Q41966819-3D0B35B6-522F-4AFA-AD91-5CF565FA3402

Q41966819-3F5C6C23-081F-40BA-AF2A-B99262C26F94

Q41966819-59008660-CA35-4D75-A852-0BE2845D2C9C

Q41966819-5B0FBCF5-1354-4E11-8254-6397AEDC79C6

Q41966819-66C439ED-DB50-4AEA-8597-6F6F4F56ABA9

Q41966819-7A6D836D-47B4-4B3C-968F-E8DFF106AFBD

P304

Q41966819-28ED824A-E075-416B-92C4-33E517BBFC12

P31

Q41966819-6E8D6680-86E5-49C2-A3B4-BEBFC2347788

P356

Q41966819-5A674AE1-C36D-4393-A547-C54C8DA1DB96

P407

Q41966819-8D55D151-606E-4129-BFEE-72E0B59810BA

P433

Q41966819-DF67ED81-8861-4153-A697-A84BE4033C34

P478

Q41966819-369D954B-A422-4E50-B6A7-A189C65D2BD7

P577

Q41966819-57FEB8C7-1597-48E5-8FD9-4E20B6970142

P698

Q41966819-5A9E7FF5-FF89-4901-87B0-A74FA01A63DC

P932

Q41966819-E807741C-8265-4E43-A3D8-EFB80B221D37

P356

P1433

Journal of Clinical Investigation

P1476

Role of leptin and melanocortin signaling in uremia-associated cachexia

@en

P2093

Brian M Little

http://www.w3.org/2001/XMLSchema#string

Daniel L Marks

http://www.w3.org/2001/XMLSchema#string

Pin X Yu

http://www.w3.org/2001/XMLSchema#string

Robert H Mak

http://www.w3.org/2001/XMLSchema#string

Roger D Cone

http://www.w3.org/2001/XMLSchema#string

Wai Cheung

http://www.w3.org/2001/XMLSchema#string

P2860

Role of melanocortinergic neurons in feeding and the agouti obesity syndrome

Targeted disruption of the melanocortin-4 receptor results in obesity in mice

Central nervous system control of food intake

Mechanisms causing muscle proteolysis in uremia: the influence of insulin and cytokines.

Role of the central melanocortin system in cachexia.

Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes

Melanocortin receptors: their functions and regulation by physiological agonists and antagonists.

Leptin regulation of the immune response and the immunodeficiency of malnutrition.

Relative contributions of nutrition and inflammation to clinical outcome in dialysis patients.

P304

1659-1665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI22521

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15931394

http://www.w3.org/2001/XMLSchema#string

P932

1136984

http://www.w3.org/2001/XMLSchema#string